2 completed, 1 unknown. 2 Phase 2, 1 Early Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Tolcapone 200 MG: new trials by email Literature Review of Tolcapone 200 MG trials Research Report on Tolcapone 200 MG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dopaminergic Mechanisms Underlying Human Social Behavior Tolcapone 200 MG, Functional Magnetic Resonance Imaging (fMRI) - Decision Making, Executive Function | Early Phase 1 | Completed | University of California, Berkeley | 70 | 2019-12-01 | 2024-05-16 |
| Tolcapone in Obsessive Compulsive Disorder Tolcapone 200 MG - Obsessive-Compulsive Disorder | Phase 2 / Phase 3 | Completed | University of Chicago | 20 | 2018-03-20 | 2022-04-07 |
| A Trial Evaluating Effects of COMT Inhibition in Patients With Acquired Brain Injury Tolcapone 200 MG, Placebo - Brain Injuries, Brain Injuries, Traumatic | Phase 2 | Unknown | Sheppard Pratt Health System | 16 | 2017-07-20 | 2017-09-06 |
Brain Injuries (1) · Brain Injuries, Traumatic (1) · Brain Injury, Chronic (1) · Obsessive-Compulsive Disorder (1)
Sheppard Pratt Health System (1) · University of California, Berkeley (1) · University of Chicago (1)
United States (3)
Jon E Grant, JD,MD,MPH (1) · Ming Hsu, PhD (1) · Robert J Schloesser, MD (1)